Hints and tips:
...It also said the divestiture does not include Cardinal Health’s other businesses in China, which include Cordis, a recently acquired Patient Recovery business....
...In 2015, Cardinal Health acquired Cordis from J&J for about $2bn, adding a portfolio of medical devices, including catheters, filters and stents....
...J&J has instead focused on “pruning” its medical devices unit, and earlier this year completed the $2bn sale of Cordis, which makes cardiovascular catheters and stents, to Cardinal Health....
...The sale of Cordis, which makes medical devices such as heart stents, for $1.94bn in cash, marked J&J’s second big divestment in just over a year after selling a blood-testing business to Carlyle Group for...
...Omar Ishrak, chairman and chief executive of Medtronic, said the combined group would hold market-leading positions in neurovascular technologies for treating Parkinson’s disease and strokes, and would have...
...Conor will operate as part of J&J’s Cordis franchise, which focuses on drug-eluting stents....
...Cordis Corporation, which is owned by J&J and develops interventional vascular technology, had charged Boston Scientific with using its balloon-explandable stent technology in three products....
...Guidant, whose product range includes pacemakers, implantable defibrillators, which correct irregular heartbeats using electric shocks, and cardiac surgery solutions, will join J&J’s stent-making business, Cordis...
International Edition